Assessment of venous thromboembolic disease (VTE) in medical patients who presented to the Launceston General Hopspital (LGH)

None listed

This study will investigate all medical patients who potentially at risk of developing blood clots (venous thrombo-embolism [VTE]) at any age group who are treated at the Launceston General hospital (LGH). We will study all factors that may influence clot formation such as Age, Weight, Gender, Mobility, presence of co-morbidities, presence of cancer, Personal history of VTE, Family history of VTE, other risk factors for VTE, additional laboratory markers such as blood count, coagulation study. The data of the trial will help to understand and know the risk factors for developing clots (VTE) among medical patients. This trial has the potential to change the treatment approach and the preventive strategies for medical patients in order to improve outcome and benefit all patients avoiding a relatively common VTE-complications of the treatment. This trial also reviewing the current protocols for prevention of VTE during the treatment of medical patients.